kras g12c inhibitors: acquired resistance and combo strategies
Published 4 years ago • 616 plays • Length 5:23Download video MP4
Download video MP3
Similar videos
-
4:29
mechanisms of acquired resistance to kras g12c inhibition in cancer
-
3:17
mechanisms of resistance to kras g12c inhibitors
-
2:53
kras g12c inhibition in advanced nsclc: mrtx849
-
4:09
kras g12c inhibition in advanced nsclc: amg 510
-
2:09
esmo highlights: kras g12c inhibitors
-
1:12
overcoming resistance to kras g12c inhibitors in nsclc
-
2:38
key lung cancer updates: kras(g12c) inhibitors and adcs
-
3:56
kras g12c inhibitors versus chemotherapy in second line - targeted therapies in lung cancer 2023
-
0:44
ascertaining the mechanisms of resistance to krasg12c inhibitors
-
0:58
kras g12c inhibitors for gi cancer
-
7:51
kras g12c inhibition in advanced nsclc: amg 510
-
0:50
kras g12c emerges as new potential target in non-small cell lung cancer
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
1:26
krystal-1 and codebreak 100: targeting kras g12c in lung cancer
-
1:37
expert discusses kras g12c inhibitors for patients with nsclc
-
1:18
combination therapies involving kras g12c inhibitors in lung cancer
-
2:40
krystal 7 study: adagrasib /- pembrolizumab for kras g12c nsclc -targeted therapies in lung cancer
-
5:29
development of kras g12c-targeted therapy in nsclc
-
1:31
optimizing and overcoming resistance to current kras inhibitors